Notice Number: NOT-CA-19-055
Key Dates
Release Date: June 18, 2019
Issued by
National Cancer Institute (NCI)
Purpose
The purpose of this Notice is to revise the Award Budget Information for PAR-18-801 "Cancer Prevention, Diagnosis, and Treatment Technologies for Low-Resource Settings (R43/R44 - Clinical Trial Optional)."
This change will be effective immediately for the next Application due date, which is September 5, 2019.
Part 2. Section II. Award Information
Currently reads:
Award Budget
It is anticipated that projects appropriate to this NCI FOA will qualify for an SBA budget waiver. Therefore, budgets up to $300,000 total costs for Phase I, and up to $2,000,000 total costs for Phase II may be requested.
Modified to Read (in italics):
Award Budget
It is anticipated that projects appropriate to this NCI FOA will qualify for an SBA budget waiver. Therefore, budgets up to $400,000 total costs for Phase I, and up to $2,000,000 total costs for Phase II may be requested.
All other aspects of this FOA remain the same.
Inquiries
Please direct all inquiries to:
Ming Zhao, PhD
National Cancer Institute (NCI)
Telephone: 240-276-5225
Email: [email protected]